CIK 0001583648 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in NV · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 42.8 M | 31.4 M | ||
| Net income (USD) | -33.3 M | -45.7 M | ||
| Diluted EPS (USD/shares) | -3.71 | 2.17 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-14 | 4 | OWNERSHIP DOCUMENT | 2026-10-12 |
| 2026-10-13 | 144 | 144 | |
| 2026-09-18 | 4 | OWNERSHIP DOCUMENT | 2026-09-16 |
| 2026-09-16 | 144 | 144 | |
| 2026-09-15 | 4 | OWNERSHIP DOCUMENT | 2026-09-11 |
| 2026-09-11 | 144 | 144 | |
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 2026-09-02 |
| 2026-09-02 | 144 | 144 | |
| 2026-08-20 | 4 | OWNERSHIP DOCUMENT | 2026-08-19 |
| 2026-08-19 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-04 | S-8 | FORM S-8 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-04 |
| 2026-08-03 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-17 | 4 | OWNERSHIP DOCUMENT | 2026-07-15 |
| 2026-07-15 | 144 | 144 | |
| 2026-07-14 | 8-K | 8-K items 8.01,9.01 | 2026-07-14 |
| 2026-07-01 | 4 | OWNERSHIP DOCUMENT | 2026-06-29 |
| 2026-07-01 | 3 | OWNERSHIP DOCUMENT | 2026-06-29 |
| 2026-06-30 | 8-K | FORM 8-K items 5.02 | 2026-06-29 |
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 2026-06-17 |
Forms on file (last 1,000): 8-K 212, 4 202, 3 41, 10-Q 38, SC 13G/A 34, CORRESP 20, SC 13G 20, 424B3 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PVLA (0.002 USD), /gw/filings/filings?ticker=PVLA&form=8-K, /gw/filings/facts?ticker=PVLA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange